Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

TVM Capital

Founders Rolf Christof Dienst

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 102
Average round size
info
The average size of a deal this fund participated in
$19M
Portfolio companies 55
Rounds per year 2.55
Lead investments 13
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.46
Exits 32
Key employees 6
Stages of investment
Early Stage Venture
Late Stage Venture
Private Equity

Areas of investment

  • Biotechnology
  • Health Care
  • Pharmaceutical
  • Software
  • Medical
Summary

TVM Capital is the famous VC, which was founded in 1983. The fund was located in Europe if to be more exact in Germany. The main department of described VC is located in the Munich.

The important activity for fund was in 2007. The typical startup value when the investment from TVM Capital is 10-50 millions dollars. The fund is constantly included in 2-6 deals per year. Deals in the range of 10 - 50 millions dollars are the general things for fund. Comparing to the other companies, this TVM Capital performs on 0 percentage points more the average number of lead investments. Considering the real fund results, this VC is 1 percentage points less often commits exit comparing to other organizations. The higher amount of exits for fund were in 2014.

This organization was formed by Rolf Christof Dienst. We also calculated 6 valuable employees in our database.

For fund there is no match between the country of its foundation and the country of its the most frequent investments - United States. Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight Vivoryon Therapeutics, Rapid Micro Biosystems, VPIsystems. The fund has specific favorite in a number of founders of portfolio startups. When startup sums 5+ of the founder, the probability for it to get the investment is little. Among the most successful fund investment fields, there are Pharmaceutical, Manufacturing.

The standard case for the fund is to invest in rounds with 4-5 partakers. Despite the TVM Capital, startups are often financed by Atlas Venture, Crescendo Ventures, 3i Group. The meaningful sponsors for the fund in investment in the same round are Skyline Ventures, Atlas Venture, Next47. In the next rounds fund is usually obtained by Skyline Ventures, Longitude Capital, Intersouth Partners.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of TVM Capital:
Typical Co-investors
TVM Capital is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after TVM Capital:

Funds with similar focus

Funds from Germany
Funds with similar focus located in Germany:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Rapid Micro Biosystems

Biotechnology
Manufacturing
Pharmaceutical
$25M29 Apr 2015 Massachusetts, United States

F-star Therapeutics

Biopharma
Biotechnology
Pharmaceutical
$9M23 Oct 2013 Cambridge, England, United Kingdom

Rapid Micro Biosystems

Biotechnology
Manufacturing
Pharmaceutical
$32M26 Jun 2013 Massachusetts, United States

Proteon Therapeutics

Biotechnology
Medical
Pharmaceutical
$15M12 Aug 2011 Massachusetts, United States

Bluebird Bio

Biotechnology
Genetics
Health Diagnostics
Pharmaceutical
$30M20 Apr 2011 Cambridge, Massachusetts, United States

Anchor Therapeutics

Biotechnology
Pharmaceutical
Therapeutics
$10M20 Aug 2010 Cambridge, Massachusetts, United States

Abionyx Pharma

Biotechnology
Health Care
$59M25 Jul 2010 Balma, Midi-Pyrenees, France

Bluebird Bio

Biotechnology
Genetics
Health Diagnostics
Pharmaceutical
$35M12 Mar 2010 Cambridge, Massachusetts, United States

F-star Therapeutics

Biopharma
Biotechnology
Pharmaceutical
$9M06 Jan 2010 Cambridge, England, United Kingdom

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent TVM Capital?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 102
Average round size 19M
Rounds per year 2.55
Peak activity year 2008
Lead investments 13
Follow on index 0.46
Exits 32
Group Appearance index 0.97

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Rapid Micro Biosystems

Biotechnology
Manufacturing
Pharmaceutical
$25M29 Apr 2015 Massachusetts, United States

F-star Therapeutics

Biopharma
Biotechnology
Pharmaceutical
$9M23 Oct 2013 Cambridge, England, United Kingdom

Rapid Micro Biosystems

Biotechnology
Manufacturing
Pharmaceutical
$32M26 Jun 2013 Massachusetts, United States

Proteon Therapeutics

Biotechnology
Medical
Pharmaceutical
$15M12 Aug 2011 Massachusetts, United States

Bluebird Bio

Biotechnology
Genetics
Health Diagnostics
Pharmaceutical
$30M20 Apr 2011 Cambridge, Massachusetts, United States

Anchor Therapeutics

Biotechnology
Pharmaceutical
Therapeutics
$10M20 Aug 2010 Cambridge, Massachusetts, United States

Abionyx Pharma

Biotechnology
Health Care
$59M25 Jul 2010 Balma, Midi-Pyrenees, France

Bluebird Bio

Biotechnology
Genetics
Health Diagnostics
Pharmaceutical
$35M12 Mar 2010 Cambridge, Massachusetts, United States

F-star Therapeutics

Biopharma
Biotechnology
Pharmaceutical
$9M06 Jan 2010 Cambridge, England, United Kingdom
Crunchbase icon

Content report

The following text will be sent to our editors: